Christophe Nicot
Has grant
Professor
United StatesResearch Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
About
Christophe Nicot is a Professor at the University of Kansas Medical Center in the United States. His research primarily focuses on cancer biology, particularly in areas such as PARP inhibition, immune evasion mechanisms, and the role of cytokines in the tumor microenvironment. Recent publications highlight his contributions to understanding drug resistance in cancer therapies and the molecular mechanisms of HTLV-1 associated diseases.
Recent Grants
Grant: Close
Role of Tax and HBZ in HTLV-1C replication in vivo
Open Date: 2022-08-01
Close Date: 2024-07-31
Grant: Close
How HTLV-I Tax and HBZ control telomerase activity to induce adult T-cell leukemia
Open Date: 2016-07-01
Close Date: 2022-06-30
Grant: Close
Role of HTLV-I Tax-induced NF-kB in activation of ICN1 and immortalization of vir
Open Date: 2013-01-17
Close Date: 2014-12-31
Grant: Close
Role of miR-124a in HTLV-I oncogenesis
Open Date: 2011-07-01
Close Date: 2013-06-30
Grant: Close
Uncoupling of Jak/STAT in HTLV-1 associated leukemia
Open Date: 2007-07-17
Close Date: 2012-05-31
Articles (10)
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2023
Collaborators (5)
Bobby Brooke Herrera
Assistant Professor
Rutgers Robert Wood Johnson Medical School New Brunswick
Paul Chi-Lui Ho
National University of Singapore (NUS)
Pooja Jain
Drexel University College of Medicine
Marcia Bellon Bellon
University of Kansas Medical Center
Lishomwa Ndhlovu
Professor
Weill Cornell Medical College
ApplyKite TwinLearns as you applyMake your next move.
Prepare your application
Review drafts before you send them.